Introduction {#s1}
============

The gluten proteins are a complex group of more than 50 proteins that have been intensively studied because of their important contributions to the commercial value of wheat. These proteins comprise 70%--80% of wheat flour protein, contain regions of very repetitive sequences with large proportions of glutamine (Q) and proline (P), and are responsible for the unique viscoelastic properties of the flour. The gluten proteins include glutenins, polymeric proteins that contribute elasticity to wheat flour dough, and gliadins, monomeric proteins that contribute extensibility to dough. The glutenins are composed of high molecular-weight glutenin subunits (HMW-GS) and low-molecular weight glutenin subunits (LMW-GS) that are linked by disulfide bonds whereas the gliadins consist of four distinct types of proteins, referred to as alpha, gamma, delta and omega gliadins (reviewed by [@B38]). Most hexaploid wheat cultivars contain six or less HMW-GS genes. However, the numbers of genes within the complex gliadin and LMW-GS families were not known until the completion of a high-quality genome sequence from the reference wheat Chinese Spring ([@B22]) made it possible to assemble and annotate a complete set of gluten protein genes from a single hexaploid cultivar ([@B20]; [@B21]). In Chinese Spring, the sequences of 47 alpha gliadin, 14 gamma gliadin, five delta gliadin, 19 omega gliadin, and 17 LMW-GS genes were reported. Of these, 26 alpha, 11 gamma, two delta, and five omega gliadin, and 10 LMW-GS genes encode full-length proteins.

In addition to their role in end-use quality, the gluten proteins also trigger celiac disease (CD), a chronic autoimmune disease that affects 1.4% and 0.7% of the population worldwide, based on serology and biopsy assessments, respectively ([@B39]). CD occurs in genetically susceptible individuals that carry the human leukocyte antigen (HLA) genes DQ2 and/or DQ8 and results in damage to the lining of the intestine and malabsorption of nutrients that are manifested in a wide range of intestinal and extraintestinal symptoms ([@B24]). It is likely that the high glutamine and proline contents of the gluten proteins contribute to their immunogenic properties. The average Q + P content for gluten proteins in the different classes ranges from \~45% (delta gliadins) to 73% (omega gliadins). As a result, these proteins are highly resistant to proteolytic degradation within the gastrointestinal tract. The high Q + P contents of the gluten proteins also makes them good substrates for tissue transglutaminase, an enzyme in the small intestine that converts glutamine to negatively charged glutamate residues. Deamidation of gluten peptides increases their binding affinity for HLA-DQ2 and -DQ8 on antigen presenting cells, allowing them to be processed and presented to T-cells to trigger an inflammatory immune response.

Epitopes relevant to CD have been identified within all of the major classes of gluten proteins ([@B40]). Five epitopes from alpha gliadins include the core sequences PFPQPQLPY, PYPQPQLPY, PQPQLPYPQ, FRPQQPYPQ, and QGSFQPSQQ. In some alpha gliadins, six epitopes overlap in a 33-mer protease-resistant peptide that has been found to be particularly toxic ([@B36]). Sixteen of the 26 alpha gliadins from Chinese Spring (62%) contain from one to eight CD epitopes. However, only one alpha gliadin encoded by the D genome contains the 33-mer toxic peptide. The greatest number of epitopes are found in proteins encoded by the D genome while nine of 11 alpha gliadins encoded by the B genome and one alpha gliadin encoded by the D genome do not contain any previously described epitopes ([@B21]; [@B12]). Eight CD epitopes have been described in gamma gliadins, including PQQSFPQQQ, IQPQQPAQL, QQPQQPYPQ, SQPQQQFPQ, PQPQQQFPQ, PQPQQPFCQ, QQPFPQQPQ, and QQPQQPFPQ. All gamma gliadins from Chinese Spring contain from five to ten CD epitopes ([@B12]). Two epitopes, PFPQPQQPF and PQPQQPFPW, were identified in omega-1,2 gliadins, a subset of omega gliadins. All omega-1,2 gliadins from Chinese Spring contain these epitopes as well as multiple copies of the QQPQQPFPQ and QQPFPQQPQ gamma gliadin epitopes. Two epitopes have been described for LMW-GS, PFSQQQQPV and FSQQQQSPF. Seven of the ten LMW-GS in Chinese Spring contain from one to three of these epitopes. Finally, one epitope was identified in HMW-GS, QGYYPTSPQ ([@B40]). In general, epitopes from alpha and omega gliadins are immunodominant ([@B41]), possibly because these epitopes have a greater number of proline residues and may be more resistant to proteolytic digestion.

Currently, the only effective treatment for CD is a lifelong gluten-free diet. Thus, there is a critical need for new approaches to reduce the immunogenic potential of wheat flour. However, these studies are challenging because of the large numbers of different wheat cultivars that are grown around the world, the tremendous allelic variation in gluten protein genes among cultivars and the large number of immunogenic sequences in all of the major classes of gluten proteins. A number of studies have focused on identifying cultivars that are low in CD epitopes using DNA sequencing, quantitative protein analyses, antibody screening or targeted mass spectrometry methods ([@B42]; [@B33]; [@B43]; [@B29]; [@B30]; [@B26]; [@B28]). Other studies have used gene silencing to reduce the amounts of immunogenic proteins in wheat flour. In a recent study, RNA interference (RNAi) was used to eliminate omega-1,2 gliadins from wheat flour ([@B13]). This was accomplished without notable effects on the levels of other gluten proteins in the flour. Flour from the resulting transgenic plants showed decreased reactivity to IgG and IgA antibodies from a cohort of CD patients as well as improved mixing properties relative to the nontransgenic control. A number of other studies have focused on the more complex family of alpha gliadins. [@B15] and [@B16] used RNAi to target all alpha gliadin genes. While the alpha gliadins were reduced significantly in both studies, there were numerous changes in the levels of other gluten proteins in the resulting transgenic lines. [@B32] used genome editing to introduce mutations into a conserved region in the alpha gliadin genes. Alpha gliadins were reduced from 32%--82% in the resulting plants. However, reductions in alpha gliadins were accompanied by significant changes in the levels of most other types of gluten proteins. While off-target and compensatory effects on the proteome have been observed, little is known about how the proteome adjusts to significant reductions in proteins that normally comprise as much as 15%--20% of the total protein or the molecular mechanisms involved. In this study, the goal was to use RNA interference to silence only those alpha gliadin genes containing known CD epitopes with the hope that the immunoreactivity of the flour might be reduced with minimal effects on the proteome. The work highlights some of the challenges faced in experiments aimed at eliminating specific proteins within large families of gluten proteins with very similar and repetitive sequences.

Material and Methods {#s2}
====================

Plant Material {#s2_1}
--------------

The U.S. hard red spring wheat *Triticum aestivum* cv. Butte 86 was used for all studies. All plant material was grown in a temperature-controlled greenhouse with daytime/nighttime temperatures of 24/17°C as described previously ([@B7]). Plants were supplied with water mixed with 0.6 g/l of Peters Professional 20-20-20 water-soluble fertilizer (Scotts-Sierra Horticultural Products Company, Marysville, OH) by a drip irrigation system.

RNAi Construct and Transformation of Plants {#s2_2}
-------------------------------------------

A 608-bp DNA fragment designed to target alpha gliadins was synthesized by GenScript (Piscataway, NJ) and cloned into the vector pUC57. The 608-bp fragment consisted of a 14-bp region that included a Hpa I restriction site, a 217-bp trigger in sense orientation, a 146-bp spacer region corresponding to an intron from a wheat starch synthase gene, a 217-bp trigger in antisense orientation, and a 14-bp spacer that included a Hpa I restriction site. This plasmid was digested with Hpa I (New England Biolabs, Ipswich, MA). Following purification, the fragment was ligated into the Hpa I site of the plasmid pJL10P5 between the promoter from the HMW-GS Dy10 gene and the terminator from the HMW-GS Dx5 gene as described in [@B6]. The final construct, referred to as Bazooka-pJL10P5-\#6, was verified by DNA sequencing. Bazooka-pJL10P5-\#6 and the plasmid pAHC20 that facilitates selection of transgenic plants with phosphinothricin ([@B17]) were used to transform Butte 86 wheat plants as described in detail in [@B6]. Putative transgenic plants were identified by PCR analysis using primers described in [@B6]. Initial screening of gliadin fractions from grain by SDS-PAGE was also described in [@B6]. Lines in which alpha gliadins were significantly down-regulated were identified and homozygous plants were selected in subsequent generations.

Protein Extraction and Analysis by Two-Dimensional Gel Electrophoresis (2-DE) {#s2_3}
-----------------------------------------------------------------------------

Triplicate samples of grain from selected lines were milled into flour using a Quadrumat Senior experimental flour mill following AACCI Method 26.10.02 (AACC Int., 1988). Total proteins were extracted from the resulting flour, quantified using a modified Lowry assay and analyzed on triplicate 2-D gels using capillary tube gels with a pI range of 3 to 10 in the first dimension and NuPAGE 4%--12% BIS-Tris protein gels in the second dimension (Life Technologies, Carlsbad, CA) as described in detail in [@B18]. Following staining with Coomassie G-250 (Sigma Aldrich, St. Louis, MO), the gels were digitized using a calibrated scanner. 2-D gels used for the analysis are shown in [**Supplementary File 1**](#SM1){ref-type="supplementary-material"}. Individual gel spots were aligned between gels and quantified using SameSpots Version 5.0 (Nonlinear Dynamics Limited, Newcastle upon Tyne, UK). Statistical analyses of spot volume data were conducted using the SameSpots software. Identifications of individual protein spots in the Butte 86 nontransgenic line were as reported in [@B18] or as determined in this study. Individual spots in transgenic lines were deemed to show significant changes from the nontransgenic if they had ANOVA values \< 0.02 and had changes in average normalized spot volumes that were greater than 20%.

Identification of Proteins in 2-DE Spots by Tandem Mass Spectrometry (MS/MS) {#s2_4}
----------------------------------------------------------------------------

Selected protein spots from the alpha gliadin region of 2-D gels of nontransgenic and transgenic lines were excised from triplicate gels, placed in 96-well plates and digested with either chymotrypsin, thermolysin, or trypsin using a DigestPro according to the directions of the manufacturer (INTAVIS Bioanalytical Instruments AG, Cologne, Germany). The resulting samples were then analyzed using an Orbitrap Elite mass spectrometer (Thermo Scientific, San Jose, CA, USA) as described in [@B44]. Two search engines, Mascot ([www.matrixscience.com](www.matrixscience.com)) and XTandem! (<https://www.thegpm.org/TANDEM/>), were used to interrogate a database of 125,400 protein sequences. The database included Triticeae sequences downloaded from NCBI on 06-18-2018 plus Chinese Spring sequences reported by [@B20]; [@B21]; Butte 86 sequences from [@B18] and [@B9]; Xiaoyan 81 sequences from [@B45]; and common mass spectrometry contaminant sequences contained in the common Repository of Adventitious Proteins (cRAP) database (<ftp://ftp.thegpm.org/fasta/cRAP/crap.fasta>). Data from the two searches and three enzymes were compiled and further validated using Scaffold version 4.8.9 (<http://www.proteomesoftware.com/>) using a protein threshold of 99%, peptide threshold of 95% and 20 ppm mass error, and a minimum of four peptides. The mass spectrometry data have been deposited to the ProteomeXchange Consortium (<http://proteomecentral.proteomexchange.org>) *via* the PRIDE partner repository ([@B27]) with the dataset identifier PXD016930 and 10.6019/PXD016930. The protein that was assigned the greatest number of unique peptides was reported as the predominant protein for each spot. Proteins that were assigned at least half the number of unique peptides as the predominant protein are also reported for each spot along with the numbers of unique peptides, total spectra, and protein coverage for each. Summaries of MS/MS data from each spot are shown in [**Supplementary Files 2--5**](#SM1){ref-type="supplementary-material"}.

Assessment of Immune Reactivity by ELISA and 2-D Immunoblot Analysis {#s2_5}
--------------------------------------------------------------------

Serum samples from a cohort of patients with celiac disease were used to assess immune reactivity toward gluten proteins from the nontransgenic and transgenic wheat lines. The celiac disease patients included twenty with elevated levels of IgG antibody to gluten \[15 female, 17 white race, mean (SD) age 42.9 (18.5) years\] and twenty with elevated levels of IgA antibody to gluten \[13 female, 19 white race, mean (SD) age 46.7 (17.3) years\]. Positivity for IgG or IgA antibody reactivity to gluten was determined as described previously ([@B34]). All patients were biopsy proven, diagnosed with CD according to previously described criteria ([@B5]), and on a gluten-containing diet. In addition, all patients were positive for antibody reactivity to transglutaminase 2, the most sensitive and specific serologic marker of CD, determined as previously described ([@B25]). Serum samples were obtained under institutional review board-approved protocols at Columbia University. This study was approved by the Institutional Review Board of Columbia University Medical Center. Serum samples were maintained at −80°C to maintain stability.

Levels of serum IgG and IgA antibody reactivity to gluten were measured separately by enzyme-linked immunosorbent assay (ELISA) as described in [@B12]. All serum samples were tested in duplicate. Absorbance values were corrected for nonspecific binding by subtraction of the mean absorbance of the associated uncoated wells and corrected values were normalized according to the mean value of the positive controls on each plate. The change in immune reactivity towards the transgenic wheat lines in comparison to the nontransgenic line, as determined by ELISA, was assessed by the Wilcoxon matched-pairs test. All P values were two-sided and differences were considered statistically significant at P \< 0.05. Statistical analyses were performed with Prism 8 (GraphPad) software.

IgG and IgA antibody reactivity to gluten proteins was further analyzed by two-dimensional immunoblotting as described in detail in [@B13].

Analysis of Flour End-Use Quality {#s2_6}
---------------------------------

End-use functionality tests were conducted at the USDA-ARS-HWWQL (Manhattan, KS) using standardized methods approved by American Association of Cereal Chemists International (AACCI). Flour protein content was determined by NIR using AACCI method 39-11.01 (AACC Int., 1985), mixing properties were determined on 10 g flour samples (14% mb) using a Mixograph (TMCO, National Mfg., Lincoln, NE) and AACCI Method 54-40.02 (AACC Int., 1995), and SDS sedimentation tests were done according to AACCI Method 56-60.01 (AACC Int., 1961). Averages and standard deviations from triplicate samples were calculated for each wheat line.

Results {#s3}
=======

Design of the Trigger for the RNAi Construct {#s3_1}
--------------------------------------------

The 217 bp trigger for the RNAi construct consisted of three distinct fragments of 74, 65, and 78 bp that were based on sequences of 13 full-length alpha gliadin coding regions assembled from Butte 86 expressed sequence tags (ESTs) available at the time the study was initiated ([@B8]). All three target fragments encode a portion of the first nonrepetitive region of the alpha gliadin that lies between the two poly Q regions ([**Figure 1**](#f1){ref-type="fig"}). Target 1, a 74-bp fragment with the sequence AAAGTACTTACCAGCTGGTGCAACAATTGTGTTGTCAGCAGCTGTGGCAGATCCCCGAGCAGTCGCGGTGCCAA, was a perfect match with alpha gliadins Bu-1, Bu-2, Bu-3, Bu-4, and Bu-10 ([**Table 1**](#T1){ref-type="table"}). These genes are likely from the D genome and encode proteins containing from three to eight CD epitopes. This fragment also had 25 bp of identity with Bu-11. Target 2, a 65-bp fragment with the sequence TTGCAAGAATTGTGTTGTCAGCACCTATGGCAGATCCCTGAGCAGTCGCAGTGCCAGGCCATCCA, was a perfect match with Bu-5 and Bu-14, likely from the A genome and encoding proteins containing two CD epitopes, while Target 3, a 78-bp fragment with the sequence AAGTATTGCAGCAAAGTAGTTACCAAGTGTTGCAACAATTATGTTGTCAGCAGCTGCGGCTGATCCCCGAGCAGTCGC, was a perfect match with Bu-11 encoding a protein with one CD epitope. The 78-bp fragment also had 25 bp of identity with Bu-12 that encodes a protein without any epitopes. Seven alpha gliadin genes from Butte 86 had 19 or less bp of identity with Target 1 while 11 genes had 19 or less bp of identity with either Target 2 or Target 3. None of the targets had identities greater than 19 bp with Bu-8, Bu-13, Bu-23, or Bu-27, all of which are likely to be from the B genome in Butte 86 and encode proteins devoid of CD epitopes.

![Comparison of alpha gliadins from Butte 86 and selection of target regions for the RNAi construct. Celiac disease (CD) epitope sequences within the alpha gliadins are shown in red and the 33-mer toxic peptide is underlined. Proteins that were targeted in RNAi experiments are shaded. The 74, 65, and 78 bp fragments used in the RNAi construct correspond to regions of the proteins shown in the blue, red, and green boxes, respectively. Protein sequences were derived from genes assembled from Butte 86 expressed sequence tags reported in [@B8].](fpls-11-00020-g001){#f1}

###### 

Identities of target sequences used in trigger of RNAi construct to alpha gliadin genes from Butte 86.

  Alpha gliadin gene   \# CD epitopes in protein   Longest region of identity (bp)          
  -------------------- --------------------------- --------------------------------- ------ ------
  Bu-1                 8                           74                                16     17
  Bu-2                 4                           74                                16     17
  Bu-3                 8                           74                                16     17
  Bu-4                 4                           74                                16     17
  Bu-5                 2                           17                                65     \<16
  Bu-8                 0                           19                                19     \<16
  Bu-10                3                           74                                16     17
  Bu-11                1                           25                                \<16   78
  Bu-12                0                           \<16                              \<16   25
  Bu-13                0                           19                                19     \<16
  Bu-14                2                           16                                65     \<16
  Bu-23                0                           19                                19     \<16
  Bu-27                0                           19                                19     \<16

^1^74 bp target sequence is AAAGTACTTACCAGCTGGTGCAACAATTGTGTTGTCAGCAGCTGTGGCAGATCCCCGAGCAGTCGCGGTGCCAA.

^2^65 bp target sequence is TTGCAAGAATTGTGTTGTCAGCACCTATGGCAGATCCCTGAGCAGTCGCAGTGCCAGGCCATCCA.

^3^78 bp target sequence is AAGTATTGCAGCAAAGTAGTTACCAAGTGTTGCAACAATTATGTTGTCAGCAGCTGCGGCTGATCCCCGAGCAGTCGC.

Because the collection of alpha gliadin sequences from Butte 86 is incomplete, the specificities of the target sequences also were assessed using the complete set of 26 full-length alpha gliadin genes that was recently reported from the reference wheat Chinese Spring ([@B21]) ([**Table 2**](#T2){ref-type="table"}). Five alpha gliadins encoded by the D genome (CS-D4, CS-D5, CS-D6, CS-D8, CS-D9) were perfect matches with Target 1, four encoded by the A genome (CS-A4, CS-A5, CS-A9, CS-A10) were perfect matches with Target 2, and one encoded by the A genome (CS-A2) was a perfect match with Target 3. In addition, five genes had regions of identities between 25 and 56 bp with Target 1, one gene had a 53-bp region of identity with Target 2 and nine genes had regions of identities between 21 and 29 bp with Target 3. Only four of the 26 alpha gliadins in Chinese Spring did not have identities greater than 19 bp with any of the targeting regions. Three of these are from the B genome (CS-B7, CS-B8, CS-B9) and do not contain CD epitopes and one is from the A genome (CS-A1) and contains a single epitope. A BLASTn search also revealed that there were no regions of identity 16 bp or greater with any gamma, delta, or omega gliadins, LMW-GS, or HMW-GS from Chinese Spring, suggesting that the RNAi construct should target only alpha gliadins.

###### 

Identities of target sequences used in trigger of RNAi construct to alpha gliadin genes from Chinese Spring.

  Alpha gliadin gene   \# CD epitopes in protein   Longest region of identity (bp)          
  -------------------- --------------------------- --------------------------------- ------ ------
  CS-A1                1                           \<16                              \<16   \<16
  CS-A2                1                           25                                \<16   78
  CS-A4                2                           17                                65     \<16
  CS-A5                2                           17                                65     \<16
  CS-A6                2                           17                                62     \<16
  CS-A8                2                           17                                53     \<16
  CS-A9                1                           17                                65     \<16
  CS-A10               2                           16                                65     \<16
  CS-B3                1                           32                                \<16   22
  CS-B7                0                           19                                19     \<16
  CS-B8                0                           19                                19     \<16
  CS-B9                0                           19                                19     \<16
  CS-B11               0                           \<16                              \<16   21
  CS-B14               0                           \<16                              \<16   25
  CS-B15               0                           \<16                              \<16   25
  CS-B16               0                           \<16                              \<16   25
  CS-B17               0                           \<16                              \<16   25
  CS-B18               0                           \<16                              \<16   25
  CS-B25               1                           56                                16     17
  CS-D1                1                           45                                \<16   29
  CS-D4                3                           74                                16     17
  CS-D5                8                           74                                16     17
  CS-D6                5                           74                                16     17
  CS-D8                6                           74                                16     17
  CS-D9                6                           74                                16     17
  CS-D12               0                           27                                \<16   23

^1^74 bp target sequence is AAAGTACTTACCAGCTGGTGCAACAATTGTGTTGTCAGCAGCTGTGGCAGATCCCCGAGCAGTCGCGGTGCCAA.

^2^65 bp target sequence is TTGCAAGAATTGTGTTGTCAGCACCTATGGCAGATCCCTGAGCAGTCGCAGTGCCAGGCCATCCA.

^3^78 bp target sequence is AAGTATTGCAGCAAAGTAGTTACCAAGTGTTGCAACAATTATGTTGTCAGCAGCTGCGGCTGATCCCCGAGCAGTCGC.

Analysis of Flour Proteins From Transgenic Lines {#s3_2}
------------------------------------------------

Following transformation of Butte 86 plants and initial DNA and protein analyses, two homozygous transgenic lines showing altered alpha gliadin profiles in SDS-PAGE were selected for detailed analysis by quantitative 2-DE. Total protein profiles are shown in [**Figure 2**](#f2){ref-type="fig"} for transgenic lines SA35a-124j and SA39b-658-5, referred to as 124j and 658-5, respectively. While most alpha gliadins in the nontransgenic flour are found within the red box shown in Panel A, this region also contains some gamma gliadins, LMW-GS and the nongluten storage proteins called triticins. There are notable changes in this region of the gel for the two transgenic lines shown in panels B and C. As can be seen in the enlarged alpha gliadin regions in [**Figure 3**](#f3){ref-type="fig"}, some spots present in the nontransgenic line are missing in the transgenic lines and some are significantly reduced. Additionally, in a number of cases the suppression of a major spot found in the nontransgenic line revealed the presence of several minor spots in the transgenic lines. To investigate this further, 30 spots in the alpha gliadin region as well as two spots that lie outside of this region and were previously identified as alpha gliadins (spots 31, 32) were excised from triplicate 2-D gels of the nontransgenic Butte 86. Spots in corresponding positions in the transgenic lines as well as new spots uncovered in the transgenic lines were also excised from triplicate gels ([**Figure 3**](#f3){ref-type="fig"}). Following digestion with either chymotrypsin, thermolysin, or trypsin, all spots were analyzed by MS/MS.

![2-DE analysis of total flour proteins from the nontransgenic **(A)** and transgenic lines 124j **(B)** and 658-5 **(C)**. MW are indicated on the right and the pI range is shown above each gel. Red boxes show regions of gels containing alpha gliadins. These regions were enlarged in [**Figure 3**](#f3){ref-type="fig"}. The black and black dashed boxes show regions of gels containing HMW-GS and serpins, respectively. Proteins were identified by MS/MS in [@B18].](fpls-11-00020-g002){#f2}

![Regions of 2-D gels containing alpha gliadins from the nontransgenic **(A)** and transgenic lines 124j **(B)** and 658-5 **(C)**. Spots in which the predominant protein was identified as an alpha gliadin are shown in red, gamma gliadin in blue, delta gliadin in magenta, and LMW-GS in green. Spots with underlined numbers in panel A contained a gamma gliadin in addition to an alpha gliadin. Spots shown in black were identified as nongluten proteins while those labeled in orange did not yield identifications.](fpls-11-00020-g003){#f3}

Not surprisingly, the identifications were complex ([**Table 3**](#T3){ref-type="table"}, [**Supplementary Files 2--5**](#SM1){ref-type="supplementary-material"}). In the nontransgenic line, the predominant proteins in 20 spots were alpha gliadins (10, 11, 13, 14, 15, 17--27, 29--32). For these spots, the MS sequence coverage ranged from 29 to 89% with an average of 63%. The predominant proteins in four spots were gamma gliadins (4, 5, 9, 12) while the predominant proteins in three spots were LMW-GS (6, 7, 8). Three of the alpha gliadin spots also contained other alpha gliadins (20, 24, 26) while five also contained gamma gliadins (10, 14, 17, 22, 24). In addition, one spot contained a delta gliadin mixed with an alpha gliadin (28), one contained an avenin-like protein (16), and three contained triticins (1, 2, 3), two of which were mixed with gamma gliadins (2, 3).

###### 

Predominant proteins identified by MS/MS in 2-DE protein spots from the alpha gliadin region of nontransgenic Butte 86 and transgenic lines 124j and 658-5. The positions of the spots are shown in [**Figure 3**](#f3){ref-type="fig"}. MS data can be found in [**Supplementary Files 2--5**](#SM1){ref-type="supplementary-material"}.

  Line               Spot \#   Predominant Protein                               Accession^1^                \# Unique Peptides   \# Spectra   \% Coverage
  ------------------ --------- ------------------------------------------------- --------------------------- -------------------- ------------ -------------
  Butte 86           1         triticin                                          ACB41345                    7                    14           14
  Butte 86           2         triticin^2^                                       AAB27108                    21                   39           291
  Butte 86           3         triticin^2^                                       EMS60011                    20                   34           26
  Butte 86           4         gamma gliadin                                     Bu-Gamma5                   49                   121          68
  Butte 86           5         gamma gliadin                                     Bu-Gamma5                   79                   181          84
  Butte 86           6         LMW-GS (s-type)                                   CS-LMW-D1                   50                   109          75
  Butte 86           7         LMW-GS (m-type)                                   Bu-LMW-7                    87                   210          85
  Butte 86           8         LMW-GS (m-type)                                   AVY03606 (Bu-LMW7)          13                   23           43
  Butte 86           9         gamma gliadin                                     EMS45054 (Bu-Gamma1)        40                   80           57
  Butte 86           10        alpha gliadin^2^                                  X-Alpha18 (Bu-Alpha23)      30                   67           52
  Butte 86           11        alpha gliadin                                     Bu-Alpha23                  67                   145          77
  Butte 86           12        gamma gliadin                                     Bu-Gamma2                   61                   165          87
  Butte 86           13        alpha gliadin                                     SCW25764 (Bu-Alpha 1)       47                   100          73
  Butte 86           14        alpha gliadin^2^                                  AKC91252 (Bu-Alpha 1)       26                   53           58
  Butte 86           15        alpha gliadin                                     Bu-Alpha2                   43                   89           70
  Butte 86           16        avenin-like protein                               Bu-farinin-2                16                   34           49
  Butte 86           17        alpha gliadin^2^                                  Bu-Alpha5                   44                   120          81
  Butte 86           18        alpha gliadin                                     SCW25769 (Bu-Alpha10)       32                   53           59
  Butte 86           19        alpha gliadin                                     Bu-Alpha10                  35                   73           57
  Butte 86           20        alpha gliadin^3^                                  CS-Alpha-B11 (Bu-Alpha12)   45                   118          71
  Butte 86           21        alpha gliadin                                     Bu-Alpha5                   5                    9            29
  Butte 86           22        alpha gliadin^2^                                  Bu-Alpha4                   44                   89           77
  Butte 86           23        alpha gliadin                                     Bu-Alpha4                   82                   159          89
  Butte 86           24        alpha gliadin^2,3^                                AKC91122                    49                   122          76
  Butte 86           25        alpha gliadin                                     Bu-Alpha14                  14                   22           47
  Butte 86           26        alpha gliadin^3^                                  AKC91122                    8                    12           42
  Butte 86           27        alpha gliadin                                     CS-Alpha-B16/B17            18                   36           40
  Butte 86           28        delta gliadin^3^                                  CS-delta-D1                 11                   22           33
  Butte 86           29        alpha gliadin                                     CAY54134 (Bu-Alpha12)       51                   120          74
  Butte 86           30        alpha gliadin                                     Bu-Alpha3                   83                   165          86
  Butte 86           31        alpha gliadin                                     CS-Alpha-B3                 16                   32           39
  Butte 86           32        alpha gliadin                                     Bu-Alpha27                  33                   70           60
  transgenic 124j    1         triticin                                          ABC41345                    48                   102          46
  transgenic 124j    2         triticin                                          ABC41345                    25                   57           37
  transgenic 124j    3         triticin^2^                                       EMS60011                    40                   78           36
  transgenic 124j    4         gamma gliadin                                     Bu-Gamma5                   37                   80           72
  transgenic 124j    5         gamma gliadin                                     Bu-Gamma5                   77                   181          81
  transgenic 124j    6         LMW-GS (s-type)                                   CS-LMW-D1                   44                   80           79
  transgenic 124j    7         LMW-GS (m-type)                                   ALN96387 (Bu-LMW-7)         52                   118          71
  transgenic 124j    8         LMW-GS (m-type)                                   Bu-LMW-7                    16                   27           39
  transgenic 124j    9         gamma gliadin                                     Bu-Gamma1                   29                   59           52
  transgenic 124j    10        gamma gliadin                                     Bu-Gamma2                   40                   91           81
  transgenic 124j    12        gamma gliadin                                     Bu-Gamma2                   49                   139          83
  transgenic 124j    14        gamma gliadin                                     Bu-Gamma3                   26                   52           59
  transgenic 124j    15        gamma gliadin^2^                                  Bu-Gamma7                   18                   39           39
  transgenic 124j    16        avenin-like protein                               AEW43832                    10                   24           29
  transgenic 124j    18        gamma gliadin^2^                                  Bu-Gamma4                   19                   36           57
  transgenic 124j    19        gamma gliadin                                     ACI04093                    15                   26           34
  transgenic 124j    22        gamma gliadin                                     CS-Gamma-D3                 45                   104          74
  transgenic 124j    24        gamma gliadin                                     CS-Gamma-D3                 40                   76           71
  transgenic 124j    27        glyceraldehyde-3-phosphate dehydrogenase^6^       ANW11922                    17                   32           40
  transgenic 124j    28        delta gliadin                                     CS-delta-D1                 30                   59           59
  transgenic 124j    33        LMW-GS (m-type)^2^                                Bu-LMW-7                    19                   29           39
  transgenic 124j    34        gamma gliadin^4^                                  Bu-Gamma3                   16                   31           37
  transgenic 124j    35        glyceraldehyde-3-phosphate dehydrogenase^2^       ALE18233                    14                   24           36
  transgenic 124j    36        LMW-GS (m-type)                                   CS-LMW-D7                   35                   109          59
  transgenic 124j    37        gamma gliadin^5,6^                                EMS45054                    7                    11           15
  transgenic 124j    38        triticin                                          EMS60011                    12                   19           25
  transgenic 124j    39        gamma gliadin                                     EMS45054                    6                    14           15
  transgenic 124j    40        gamma gliadin                                     Bu-Gamma8                   14                   30           32
  transgenic 124j    41        gamma gliadin                                     Bu-Gamma5                   17                   34           37
  transgenic 124j    42        gamma gliadin                                     Bu-Gamma5                   19                   39           39
  transgenic 658-5   1         triticin                                          ACB41345                    28                   69           43
  transgenic 658-5   2         triticin                                          ACB41345                    22                   60           42
  transgenic 658-5   3         gamma gliadin^6^                                  Bu-Gamma5                   16                   27           33
  transgenic 658-5   4         gamma gliadin                                     Bu-Gamma5                   26                   48           52
  transgenic 658-5   5         gamma gliadin                                     Bu-Gamma5                   47                   140          69
  transgenic 658-5   6         LMW-GS (s-type)                                   CS-LMW-D1                   23                   40           61
  transgenic 658-5   7         LMW-GS (m-type)                                   Bu-LMW7                     46                   115          66
  transgenic 658-5   8         LMW-GS (m-type)                                   Bu-LMW7                     21                   36           47
  transgenic 658-5   9         gamma gliadin                                     EMS45054 (Bu-Gamma1)        17                   33           44
  transgenic 658-5   10        gamma gliadin                                     AGO17694 (Bu-Gamma2)        22                   44           60
  transgenic 658-5   12        gamma gliadin                                     AAF42989 (Bu-Gamma2)        42                   86           66
  transgenic 658-5   14        gamma gliadin                                     Bu-Gamma3                   18                   30           54
  transgenic 658-5   15        gamma gliadin                                     ACJ03439 (Bu-Gamma7)        12                   27           41
  transgenic 658-5   16        avenin-like protein                               AEW43832                    20                   47           57
  transgenic 658-5   18        gamma gliadin^2^                                  ATD83912                    20                   37           46
  transgenic 658-5   19        gamma gliadin^2,3,6^                              ACI04093                    7                    22           24
  transgenic 658-5   22        gamma gliadin                                     BAN29066                    40                   94           77
  transgenic 658-5   24        gamma gliadin                                     CS-Gamma-D3                 18                   32           51
  transgenic 658-5   28        delta gliadin                                     CS-delta-D1                 14                   27           34
  transgenic 658-5   30        glyceraldehyde-3-phosphate dehydrogenase^2,3,6^   ANW11921                    8                    15           30
  transgenic 658-5   33        no ID                                                                                                           
  transgenic 658-5   34        gamma gliadin                                     Bu-gamma3                   7                    14           24
  transgenic 658-5   35        glyceraldehyde-3-phosphate dehydrogenase          ANW11922                    16                   32           47
  transgenic 658-5   36        LMW-GS (m-type)^6^                                AFL55408                    7                    18           23
  transgenic 658-5   37        delta gliadin^2^                                  CS-delta-D1                 6                    14           24
  transgenic 658-5   38        no ID                                                                                                           
  transgenic 658-5   39        gamma gliadin^6^                                  Bu-Gamma8                   5                    11           16
  transgenic 658-5   40        no ID                                                                                                           
  transgenic 658-5   41        gamma gliadin^6^                                  Bu-Gamma5                   11                   22           35
  transgenic 658-5   42        gamma gliadin                                     Bu-Gamma5                   27                   59           60
  transgenic 658-5   43        LMW-GS (m-type)                                   CS-LMW-D7                   5                    9            18

^1^Protein accessions from Butte 86 begin with Bu and are reported in [@B18], proteins from Chinese Spring begin with CS and are reported in [@B20]; [@B21], and proteins from Xioayan 81 begin with X and are reported in [@B45]. All other accessions are from NCBI. Proteins from Butte 86 that are very similar to the protein identified by Scaffold are shown in parentheses.

^2^Spot also contains gamma gliadin.

^3^Spot also contains other alpha gliadins.

^4^Spot also contains LMW-GS.

^5^Spot also contains delta gliadin.

^6^Spot also contains non-gluten protein.

Twelve of the spots identified as alpha gliadins in the nontransgenic line were missing in transgenic line 124j (11, 13, 17, 20, 21, 23, 25, 26, 29, 30, 31, 32) while seven spots identified as alpha gliadins in the nontransgenic line were identified as gamma gliadins (10, 14, 15, 18, 19, 22, 24) in 124j. A delta gliadin was the only protein identified in spot 28 in the transgenic line. Of the ten other minor spots that were uncovered in the transgenic line, six were gamma gliadins (34, 37, 39--42), two were LMW-GS (33, 36), one was triticin (38) and one was glyceraldehye-3-phosphate dehydrogenase (35). No alpha gliadins were identified in 124j in the analysis.

Similarly, twelve spots identified as alpha gliadins in the nontransgenic line were missing in transgenic line 658-5 (11, 13, 17, 20, 21, 22, 25, 26, 27, 29, 31, 32), and the same seven spots that were identified as alpha gliadins in the nontransgenic line but gamma gliadins in 124j were also identified as gamma gliadins in 658-5 (10, 14, 15, 18, 19, 22, 24). Spot 28 in 658-5 contained only a delta gliadin and the identities of the minor spots uncovered in 658-5 were similar to those from 124j ([**Table 3**](#T3){ref-type="table"}). Alpha gliadins were identified as one of several components of two minor spots (19, 30) in 658-5.

Quantitative Analysis of Proteins in Nontransgenic and Transgenic Lines {#s3_3}
-----------------------------------------------------------------------

Most spots in which the predominant proteins were alpha gliadins in Butte 86 showed significantly reduced volumes in the transgenic lines (73% of alpha gliadin spots in 124j and 79% of alpha gliadin spots in 658-5) ([**Supplementary Files 6, 7**](#SM1){ref-type="supplementary-material"}). Decreases ranged from 25.2% to 83.9% with an average reduction of 56.6% in 124j, and 28.5% to 67.0% with an average reduction of 48.8% in 658-5. Surprisingly, a large percentage of the spots that were identified as HMW-GS also showed significantly reduced volumes (71% of HMW-GS spots in 124j and 76% of HMW-GS spots in 658-5), although the reductions were generally much smaller for the HMW-GS than the alpha gliadins. Changes in a few spots identified as omega gliadins (four of 16 spots in 124j and one of 15 in 658-5) and LMW-GS (three of 22 spots in 124j and four of 22 spots in 658-5) also were observed. In 124j, increases were observed in the volumes of spots containing a variety of nongluten proteins, including purinins, triticins, globulins, serpins and alpha amylase inhibitors (AAI) ([**Supplementary File 6**](#SM1){ref-type="supplementary-material"}) while decreases in a number of serpins were observed in 658-5 as well as increases among purinins, globulins and a few AAI ([**Supplementary File 7**](#SM1){ref-type="supplementary-material"}). It is notable that some of these proteins, including purinins, globulins, serpins and AAI may also be involved in wheat-related pathologies.

A number of adjustments were made to the normalized spot volume data for 2-DE spots containing either alpha or gamma gliadins ([**Supplementary Files 6**](#SM1){ref-type="supplementary-material"}, [**7**](#SM1){ref-type="supplementary-material"}). First, for the five Butte 86 spots in which both alpha and gamma gliadins were identified (10, 14, 17, 22, 24), average spot volumes for Butte 86 were divided among the two protein types according to the percentage of unique peptides that were obtained for each type as detailed in [**Supplementary Files 6**](#SM1){ref-type="supplementary-material"}, [**7**](#SM1){ref-type="supplementary-material"}. Second, in the transgenic lines, the average normalized volumes were assigned to gamma gliadins since gamma gliadins were the only proteins identified in these spots in these lines. Additionally, in cases where spots were identified as alpha gliadins in Butte 86 but as gamma gliadins in the transgenic lines (15, 18, 19, 22), the entire spot volume was assigned to alpha gliadins in Butte 86, but to gamma gliadins in the transgenic lines. Additionally, spot volume data for spot 28 was divided between alpha and delta gliadins in Butte 86, but assigned to delta gliadins for the transgenic lines and spot volume data for spots 27 and 30 were assigned to alpha gliadins for Butte 86, but to the nongluten protein group for lines 124j and 658-5, respectively, since the spots were identified as glyceraldehyde-3-phosphate dehydrogenase in the transgenic lines.

Overall, decreases in the amounts of alpha gliadins of 70.4% and 66.1% and decreases in the amounts of HMW-GS of 26% and 28.8% were observed in transgenic lines 124j and 658-5, respectively ([**Table 4**](#T4){ref-type="table"}). Among the HMW-GS, significant decreases were noted for all subunits except Ax2\* with the greatest decreases noted for HMW-GS Dy10 (34.7% and 42.2% for 124j and 658-5, respectively) ([**Supplementary Files 6**](#SM1){ref-type="supplementary-material"}, [**7**](#SM1){ref-type="supplementary-material"}). Serpins showed a 30.5% decrease in 658-5 but a slight increase in 124j. Small increases in the amounts of purinins were also noted in both transgenic lines as well as small increases in the amounts of some of the other nongluten proteins.

###### 

Changes in amounts of different classes of flour proteins in transgenic lines 124j and 658-5 relative to the nontransgenic.

                             \% Change   
  -------------------------- ----------- -------
  alpha gliadins             −70.4       −66.1
  gamma gliadins             15.0        1.7
  omega gliadins             8.1         −3.3
  delta gliadins             26.8        4.4
  HMW-GS                     −26.0       −28.8
  LMW-GS                     −2.6        −4.4
  purinins                   32.0        26.4
  farinins                   −0.3        −0.8
  triticins                  9.2         −2.3
  globulins                  21.9        15.2
  serpins                    21.9        −30.5
  AAI                        11.8        3.6
  other nongluten proteins   21.9        27.0

The ratio of glutenin to gliadin in the nontransgenic line was 0.94 to 0.96 while that of both transgenics was slightly higher, 1.04 for 124j and 1.06 for 658-5. The ratio of HMW-GS to LMW-GS was 0.64 and 0.67 in Butte 86, but 0.49 and 0.50 in 124j and 658-5, respectively ([**Supplementary Files 5**](#SM1){ref-type="supplementary-material"} and [**6**](#SM1){ref-type="supplementary-material"}).

Immunogenic Potential of Transgenic Lines {#s3_4}
-----------------------------------------

The immunogenic potential of the transgenic lines relative to the nontransgenic line was assessed by comparing the reactivity of antibodies from patients with biopsy-confirmed cases of CD towards flour proteins from the nontransgenic and transgenic lines. Levels of serum IgG and IgA reactivity were significantly reduced for the transgenic lines when compared to the nontransgenic line as determined by ELISA (p\< 0.0001 for all comparisons) ([**Figure 4**](#f4){ref-type="fig"}). All patients in the study had lower IgG and IgA reactivities to the transgenic lines than to the nontransgenic line, although differences were small for some patients. Reductions were similar for both transgenic lines.

![Measurement of celiac disease antibody reactivity to nontransgenic and transgenic wheat gluten proteins. Levels of antibody reactivity towards gluten proteins from nontransgenic and transgenic 124j **(A**, **B)** and 658-5 **(C**, **D)** plants are shown for each of the 20 antigluten IgG-positive **(A**, **C)** and 20 antigluten IgA-positive **(B**, **D)** celiac disease patients, as determined by ELISA. Each individual is represented by a dot and the two points corresponding to the same individual are connected by a line. Each box indicates the 25th--75th percentiles of distribution, with the horizontal line inside the box representing the median.](fpls-11-00020-g004){#f4}

The molecular specificity of immune reactivity to gluten proteins in the transgenic lines was examined by two-dimensional immunoblotting ([**Figure 5**](#f5){ref-type="fig"}). The observed decrease in levels of IgG and IgA antigluten antibodies to transgenic lines as determined by ELISA was confirmed to be due to a reduction in antibody binding to alpha gliadins. Generally, IgG and IgA antibodies from patients reacted with a number of proteins in addition to the alpha gliadins and the profiles of reactivity varied among patients. For the representative case shown in [**Figure 5A**](#f5){ref-type="fig"}, IgG antibodies from one patient exhibited reactivity with alpha gliadins, LMW-GS, serpins and purinins in the nontransgenic line, while in another case shown in [**Figure 5D**](#f5){ref-type="fig"}, IgA antibodies showed reactivity with alpha gliadins, omega-1,2 gliadins, some LMW-GS and gamma gliadins, omega-5 gliadins and AAI proteins. In both cases, the overall observed reduction in IgG and IgA antibody reactivity toward the transgenic lines was attributable to a reduction in reactivity to alpha gliadin proteins.

![Assessment of the molecular specificity of immune reactivity towards nontransgenic and transgenic wheat lines. Immunoblots show IgG **(A--C)** and IgA **(D--F)** antibody reactivity in representative celiac disease patients towards two dimensionally separated total flour proteins from nontransgenic **(A**, **D)** and transgenic plants 124j **(B**, **E)** and 658-5 **(C**, **F)**. Red boxes show the alpha gliadin regions. In panels **(A--C)**, the positions of serpins, low-molecular weight glutenin subunits (LMW-GS) and purinins are shown in solid light blue, green, and dashed light blue ovals. In panels **(D--F)**, the positions of omega-1,2 gliadins, omega-5 gliadins, LMW-GS, and AAI are shown in solid blue, dashed blue, green, and magenta ovals. MW are indicated on the left.](fpls-11-00020-g005){#f5}

End-Use Quality Analysis of Transgenic Lines {#s3_5}
--------------------------------------------

Sufficient quantities of grain from the nontransgenic and transgenic lines were produced in the greenhouse for end-use quality testing using methods that are commonly utilized to assess breeding lines in the U.S. The average kernel weight of transgenic line 124j was similar to that of the nontransgenic control, 42.7 mg +/−0.7 versus 42.8 mg +/−2.2 while that of 658-5 was 24.6% less, 32.3 mg +/−1.6. Nonetheless, grain protein contents (%) were similar in the transgenic lines and the nontransgenic control while flour protein contents (%) were somewhat less than the control in the two transgenic lines ([**Table 5**](#T5){ref-type="table"}). The overall shapes of the mixing curves generated with a 10-g mixograph were similarly poor in both the transgenic and the nontransgenic lines. However, both transgenic lines had shorter mix times and peak heights than the nontransgenic control ([**Figure 6**](#f6){ref-type="fig"}, [**Table 5**](#T5){ref-type="table"}). Water absorption decreased in flour from both transgenic lines relative to the control while mixing tolerance was poor in all lines. The SDS sedimentation volumes for the two transgenic lines were 69.2% and 59.6% less than that of the nontransgenic line, 21.1 ml/g for 124j and 27.7 ml/g for 658-5 as opposed to 68.6 ml/g for Butte 86 ([**Table 5**](#T5){ref-type="table"}).

###### 

End-use quality data from nontransgenic Butte 86 and transgenic lines 124j and 658-5.

  Line          Grain protein (%)   Flour protein^1^ (%)   Water Absorption^1^ (%)   Mix time (min)   Mix tolerance^2^   SDS sedimentation volume (ml/g)
  ------------- ------------------- ---------------------- ------------------------- ---------------- ------------------ ---------------------------------
  Butte 86^3^   19.7 (0.2)          17.4 (0.5)             73.2 (1.3)                2.0 (0.4)        0.3 (0.6)          68.6 (2.17)
  124j^3^       19.2 (0.7)          15.3 (0.6)             59.8 (0.8)                0.7 (0.1)        0.0 (0.0)          21.1 (2.71)
  658-5^3^      19.2 (0.1)          15.5 (0.1)             64.7 (1.7)                1.1 (0.1)        0.3 (0.6)          27.7 (3.55)

^1^Based on 14% moisture.

^2^Recorded on a 0--6 scale with 6 having the greatest tolerance.

^3^Averages and (standard deviations) from flour samples from three biological replicates are reported.

![10 g mixograph curves produced using flour from nontransgenic **(A)** and transgenic lines 124j **(B)** and 658-5 **(C)**. The red line shows the position of the peak mixing time in the nontransgenic line.](fpls-11-00020-g006){#f6}

Discussion {#s4}
==========

Given the large numbers of alpha gliadin genes as well as the high similarities and repetitiveness of their sequences, it can be difficult to find regions that are unique for specific genes. This is even more challenging when not all of the gene sequences from the cultivar of interest are known. In this study, only 13 alpha gliadin gene sequences were available from Butte 86 when the RNAi construct was designed. Based on the finding that Chinese Spring contains 26 genes encoding full-length alpha gliadins, it is likely that the available sequences account for only one half of the total number of gene sequences expressed in this cultivar. Nonetheless, we focused on the regions of the 13 genes encoding the first nonrepetitive portion of the proteins with the aim of designing an RNAi construct that would target only those alpha gliadins containing CD epitopes. The average percentage of Q+P in this region is much lower than that of the N-terminal and repetitive regions that were used as targets in the RNAi constructs of [@B15] and [@B16]. In fact, among the 26 alpha gliadins from Chinese Spring, the average percentage of Q+P in this region was 24.9% as opposed to 69.2% for the N-terminal and repetitive regions. Thus, it might be expected that the construct would be less likely to silence nontargeted genes or genes in other gluten protein families. To further decrease the likelihood of off-target effects, we also selected a trigger for the RNAi construct that consisted of fragments of contiguous sequence that were less than 78 bp in length. In comparison, the triggers in the [@B15] and [@B16] constructs contained 377 and 313 bp, respectively. Despite these efforts, the desired specificity was not achieved in our experiments. Rather, all alpha gliadin genes were silenced effectively in the transgenic plants, demonstrating that regions of identity less than 20 bp between the trigger and the target gene can result in silencing of gluten protein genes. This is consistent with reports that triggers with as few as 14 nucleotides of contiguous sequence complementarity sometimes result in suppression ([@B35]).

Even more surprising is the partial suppression of HMW-GS genes that was observed in the transgenic lines given that there is little identity between the trigger region and HMW-GS sequences. However, the RNAi construct did include the promoter and 5\' untranslated region from the Dy10 HMW-GS gene and the 3\' untranslated region and terminator from the Dx5 HMW-GS gene. It is thus possible that the partial reduction of HMW-GS is due to cosuppression of the HMW-GS genes as a result of homology dependent gene silencing. Silencing of endogenous genes has been reported when HMW-GS transgenes were introduced into transgenic plants ([@B14]). However, it should be noted that the same HMW-GS promoter and terminator regions were included in RNAi constructs that targeted the omega-5 and omega-1,2 gliadin genes in other studies. Partial decreases in HMW-GS were observed in one of four transgenic lines in which the omega-5 gliadins were suppressed ([@B10]), but not in lines in which the omega-1,2 gliadins were suppressed ([@B13]), suggesting that the copy number and/or site of insertion may also be important. Nonetheless, as a caution it may be wise to use avoid using regulatory regions derived from wheat gluten protein genes in future studies.

Surprisingly, there was little change in the levels of other gluten proteins in the transgenic lines as determined by quantitative 2-DE. Rather, the reductions in alpha gliadins and HMW-GS were compensated partially by increases in a number of nongluten proteins. Thus, it is possible to eliminate an entire group of gluten proteins without compensatory effects on other gluten protein classes. In contrast, [@B15] stated that decreases in alpha gliadins were offset mostly by increases in HMW-GS while [@B16] reported that lines that had the largest decreases in alpha gliadins showed increases in omega and gamma gliadins, HMW-GS, and albumins/globulins. [@B16] also observed off-target suppression of LMW-GS in some of their lines. They hypothesized that some of the reductions in LMW-GS might be due to the suppression of alpha gliadins that contain an extra cysteine and thus are linked into the glutenin polymer. However, no evidence was provided to support this notion. Undoubtedly, both off-target and compensatory effects of RNA interference are complicated, particularly among gene families as complex as the gliadins and glutenins, and therefore require further study. Indeed, one study in which omega-5 gliadins genes were silenced by RNAi yielded transgenic lines in which there were minimal off-target or compensatory effects on the proteome as well as lines that showed notable changes in protein groups other than those targeted ([@B10]). This study also employed quantitative 2-DE.

Both transgenic lines exhibited a significant reduction in binding to IgG and IgA antibodies from CD patients in comparison to the nontransgenic wheat, suggesting a decreased immunogenic potential. The reductions were similar in the two lines, as expected from their similarities in protein composition. However, the reductions were less substantive than what was observed in a previous study with transgenic plants missing the omega-1,2 gliadins ([@B13]), demonstrating the complexity and broad range of immunogenic gluten proteins in the context of celiac disease. Clearly, additional studies that address potential T cell reactivity of flour proteins from the transgenic lines are warranted. Considering the fact that the alpha gliadins contain known T cell epitopes and that most of these epitopes are located within the B cell epitope sequences, the data here suggest that T cell reactivity to the transgenic lines would also be diminished to a similar extent.

With regards to end-use quality, the decreases in mix time in the transgenic lines relative to nontransgenic Butte 86 suggest that the altered protein compositions may have a negative effect on the mixing properties of the flour. However, given the short mix time and tolerance observed in the control, it is difficult determine the significance of the effects. Nonetheless, reductions in SDS sedimentation volumes in the transgenic lines suggest that one effect of the gene silencing was a decrease in gluten strength. This is consistent with the decrease in the ratio of HMW-GS to LMW-GS that was observed in the transgenic lines and is further supported by the observed decreases in water absorption in the transgenic lines. While the most notable difference between the nontransgenic and the transgenic lines was the absence of alpha gliadins, it must be kept in mind that the HMW-GS also showed a small decrease. Because the HMW-GS have a major effect on the functional properties of the flour ([@B37]), even small decreases in these proteins could confound the interpretation of the quality data. In other transgenic studies, the effects of the alpha gliadins on flour functional properties were inconclusive. [@B16] performed small-scale rheology tests on a mixture of flour from two transgenic lines because of the small amounts of transgenic material that were available and concluded that flour from the transgenic lines did not differ from controls in dough rheology. However, gluten from the transgenic lines had a higher maximum resistance to extension and a lower extensibility than gluten from the control. [@B15] examined only SDS sedimentation volumes, but it was not possible to determine whether the increased values observed in their transgenic lines were due to the decrease in alpha gliadins or alterations in the levels of other proteins. In comparison, when omega-5 gliadins or omega-1,2 gliadins were down-regulated in transgenic plants, there was an increase in both mix time and mix tolerance, suggesting that the mixing properties of the flour were improved, and SDS sedimentation volumes were similar or slightly increased ([@B11]; [@B13]). In the future, it may be interesting to cross transgenic plants in which the alpha gliadins have been eliminated with ones in which the omega-1,2 gliadins have been eliminated and assess both flour quality and IgG and IgA antibody reactivities of the resulting lines.

An important question is whether it will be feasible to target only those alpha gliadin genes encoding proteins with CD epitopes or, alternately, a subset of genes encoding proteins with the greatest numbers of epitopes. To achieve this goal, it will be important first to obtain all of the alpha gliadin gene sequences from the cultivar of interest. The availability of a reference genome sequence from Chinese Spring makes it possible to design gene capture methods to obtain complete sets of gluten protein genes from different cultivars. This might be accomplished using a capture system that includes baits for all high-confidence exons from the International Wheat Genome Sequencing Consortium (IWGSC) genome assembly of Chinese Spring that is commercially available from Arbor Biosciences (Ann Arbor, MI). Alternately, baits for the capture system may be specific for genomic regions encoding the major gluten proteins in Chinese Spring as annotated by [@B20]; [@B21]) or based on the sequences of all known gluten genes from various Triticeae species and cultivars ([@B23]. However, even with complete sequence information it will be very challenging to identify regions that can be used as triggers in RNAi constructs given the similarities in the sequences of the different genes. Genome editing using CRISPR/Cas9 is an alternate approach that promises greater specificity since it requires only 20 bp of identical sequence for the guide RNAs that determine the sites of the mutations introduced into target genes. In addition, genome editing approaches potentially could be used to alter specific epitope sequences within alpha gliadin genes, as suggested by [@B31]. However, off-target mutations have also been reported in CRISPR/Cas9 edited plants ([@B19]). Additionally, genome editing is not simple in a family as complex as the alpha gliadins. The method can create indels of various sizes in both expressed genes and pseudogenes that either eliminate proteins or introduce new protein variants. And, when multiple genes are present in tandem in the genome, as in the case of the alpha gliadins, one or more genes may be deleted. Without a doubt, the challenges are many to achieve the long-term goal of reducing the immunogenic potential of wheat. But insight into both the complement of proteins in wheat flour and the roles that different groups of wheat gluten proteins play in determining the functional properties of the flour should make it easier to do so while retaining the unique viscoelastic properties of the flour.
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